Quantbot Technologies Reduces Stake in Progyny

Hedge fund cuts holdings in fertility benefits company by over two-thirds

Mar. 8, 2026 at 10:06am

Got story updates? Submit your updates here. ›

Quantbot Technologies LP, a New York-based investment management firm, decreased its holdings in Progyny, Inc. (NASDAQ:PGNY) by 68.6% during the third quarter of 2025, according to a filing with the Securities and Exchange Commission. The firm now owns 36,137 shares of the company's stock, down from 114,945 shares previously.

Why it matters

Progyny is a leading provider of fertility benefits management services, partnering with employers and health plans to offer comprehensive family-building programs. The reduction in Quantbot's stake could signal a shift in investor sentiment around the company's prospects, though the overall institutional ownership remains high at nearly 95%.

The details

According to the SEC filing, Quantbot Technologies sold 78,808 shares of Progyny during the third quarter, leaving the firm with a remaining position of 36,137 shares valued at $778,000. The move comes as Progyny has seen its stock price fluctuate in recent months, trading between a 52-week low of $16.75 and a high of $28.75.

  • Quantbot Technologies reduced its Progyny holdings during the third quarter of 2025.

The players

Quantbot Technologies LP

A New York-based investment management firm that decreased its stake in Progyny, Inc. by 68.6% in the third quarter of 2025.

Progyny, Inc.

A fertility benefits management company that partners with employers and health plans to offer comprehensive family-building programs.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Quantbot's Progyny holdings could signal some investor uncertainty around the company's future prospects, though the overall institutional ownership remains high. Progyny's ability to maintain its market-leading position in the fertility benefits space will be closely watched by investors in the coming quarters.